Case study: Monkeypox breakthrough infection in fully vaccin

New research to be presented at this year's European Congress of Clinical Microbiology and Infectious Diseases in Barcelona, Spain (27-30 April) details the case of a man who had received two doses of the monkey pox vaccine in Autumn, 2022 yet experienced a 'breakthrough' mpox infection in January 2024.

Related Keywords

Austria , Barcelona , Comunidad Autonoma De Cataluna , Spain , Vienna , Wien , Ankara , Turkey , Luigi Segagni Lusignani , European Society Of Clinical Microbiology , Public Health Authority , European Congress , Clinical Microbiology , Infectious Diseases , Vaccinia Ankara , Bavarian Nordic , Exposure Prophylaxis , Mpox Severity Score System , Mpox , Vaccine , Immunity , Icrobiology , Public Health , Research ,